About Elan
Elan is a company based in Dublin (Ireland) founded in 1969 was acquired by Perrigo in July 2013. Elan has completed 5 acquisitions, including AOP Orphan Pharmaceuticals, Athena Neurosciences and Delsys Pharmaceutical Corporation. Elan offers products and services including Ibuprofen Tablets, Acetaminophen, Minoxidil Topical Solution, Nicotine Polacrilex Lozenge, and Allergy Relief Loratadine. Elan operates in a competitive market with competitors including Kapiva, ChromaDex, Labomar, LifeVantage and Mojocare, among others.
- Investors
- Investments & AcquisitionsAOP Orphan Pharmaceuticals
& 4 more
- Acquired byPerrigo
(Jul 2013)
Products & Services of Elan
Elan offers a comprehensive portfolio of products and services, including Ibuprofen Tablets, Acetaminophen, Minoxidil Topical Solution, Nicotine Polacrilex Lozenge, and Allergy Relief Loratadine.
Provides relief from pain and inflammation for consumers.
Treats fever and minor aches effectively.
Promotes hair growth for men as an over-the-counter treatment.
Aids in quitting smoking by reducing cravings.
Relieves allergy symptoms like itching and sneezing.
Investors in Elan
Elan has secured backing from 1 investor. Prominent investors backing the company include Perrigo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
APIs, OTC pharmaceuticals, and nutritional products are manufactured and distributed. | 1887 | perrigo.com | Allegan, United States |
Investor details for Elan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elan
Elan has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include AOP Orphan Pharmaceuticals, Athena Neurosciences and Delsys Pharmaceutical Corporation.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Develops, produces and distributes innovative drugs and administration methods for rare diseases | aoporphan.com | Vienna, Austria | 1996 | May 2013 | $338.23M | |
Proprietary technology for pharmaceutical formulation and drug delivery is developed. | delsyspharma.com | Monmouth Junction, United States | 1977 | Sep 2001 | $50M | |
Limited information available | quadrant.co.uk | Ruddington, United Kingdom | 1995 | Feb 2001 | $75M | |
Biopharmaceutical therapies for neurological diseases and pain are developed. | neurex.com | Menlo Park, United States | 1994 | Apr 1998 | $810M | |
Limited information available | athenaneuro.com | San Francisco, United States | 1986 | Mar 1996 | $638M |
Complete acquisition details for Elan
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Elan
7 dated milestones of Elan across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Elan is founded.
- Acquisition Acquires Athena Neurosciences.
- Acquisition Acquires Neurex Corporation.
- Acquisition Acquires Quadrant Healthcare.
- Acquisition Acquires Delsys Pharmaceutical Corporation.
- Acquisition Acquires AOP Orphan Pharmaceuticals.
- Exit Acquired by Perrigo.
Competitors of Elan
Elan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, ChromaDex, Labomar, LifeVantage and Mojocare, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kapiva.in | 2016 | Bengaluru, India | $77.85M | 492 | Ayurvedic healthcare and nutritional products are provided by Kapiva. | |
| chromadex.com | 1999 | Irvine, United States | $3.39M | 228 | Nutritional ingredients for health and wellness are developed. | |
| labomar.com | 1998 | Treviso, Italy | $6.9M | – | Dietary supplements, diet foods, health products, and medical devices | |
| lifevantage.com | 2003 | Monroe, United States | – | 248 | Nutritional products for various health ailments are provided. | |
| mojocare.com | 2020 | Bengaluru, India | $23.73M | 2 | Personalized wellness solutions are delivered via a digital healthcare platform. | |
| bbetter.co | 2018 | Hyderabad, India | $1.89M | 151 | Nutritional supplements are provided to enhance health and wellness. | |
| designsforhealth.com | 1989 | Suffield, United States | – | 327 | Dietary supplements and medical foods are provided for health professionals. | |
| setu.in | 2017 | Mumbai, India | $1.72M | 200 | Dietary supplements with herbal extracts and vitamins are provided. | |
| nemysisltd.com | 2015 | Dublin, Ireland | $4.1M | – | Nano-particulate supplements are developed for iron deficiency and gluten intolerance. | |
| prophaselabs.com | 1989 | Doylestown, United States | – | 129 | Nutraceuticals and OTC health products are manufactured for disease remedies. |
Detailed competitors of Elan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Elan
Websites that share an audience with Elan (elan.com).
Websites whose visitors overlap most with Elan. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pfizer.com | 100% | 1.9M | #24,984 | View details | |
| amgen.com | 98% | 495.4K | #116,434 | View details | |
| viropharma.com | 87% | – | – | View details | |
| merck.com | 83% | 656.8K | #78,842 | View details | |
| perrigo.com | 79% | 61.1K | #524,398 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for Elan
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Elan
Complete news archive for Elan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Elan
10 companies that operate in the same segment as Elan (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | – | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 80.12 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elan
Elan was founded in 1969.
Elan is headquartered in Dublin, Ireland.
Perrigo is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) products, prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri. Nutrition products include infant formula, paediatric nutrition and vitamins, minerals, and supplements. Perrigo has acquired Neurex Corporation, Delsys Pharmaceuticals and AOP Orphan Pharmaceuticals. The company has operations in more than 30 countries across North America, Europe, Asia, South America, and Australia. Perrigo API (formerly Chemagis), a division of Perrigo develops, produces, and markets APIs and FDFs for the branded and generic pharmaceutical industries. Perrigo API has FDA-inspected and cGMP compliant facilities in Israel, Germany and India.
Elan offers Ibuprofen Tablets, Acetaminophen, Minoxidil Topical Solution, Nicotine Polacrilex Lozenge, and Allergy Relief Loratadine.
Elan has made 5 acquisitions, including AOP Orphan Pharmaceuticals, Athena Neurosciences, and Delsys Pharmaceutical Corporation.
Elan has 1 investor. Key investors include Perrigo.
Elan operates through Perrigo Company Plc.
Yes. Elan was acquired by Perrigo in July 2013.